Whitehawk Therapeutics, Inc. - Common stock (WHWK)

60 filings reported holding WHWK - Whitehawk Therapeutics, Inc. - Common stock as of Q4 2024.
Whitehawk Therapeutics, Inc. - Common stock (WHWK) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14,961,549 shares of 47,144,064 outstanding shares and own 31.74% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (2,849,402 shares), QVT Financial LP (2,313,702 shares), BML Capital Management, LLC (2,100,000 shares), ACUTA CAPITAL PARTNERS, LLC (1,849,402 shares), ACORN CAPITAL ADVISORS, LLC (1,147,052 shares), Ally Bridge Group (NY) LLC (817,939 shares), VANGUARD GROUP INC (765,992 shares), RENAISSANCE TECHNOLOGIES LLC (456,022 shares), Peapod Lane Capital LLC (442,942 shares), and EcoR1 Capital, LLC (345,253 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.